The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  January 2018 Next

The EFMC confers every two years, on the occasion of the EFMC-ISMC Symposium, three awards including the W.Th.Nauta Award on Pharmacochemistry, established by the Dutch Foundation "Stichting Prof. Dr.W.Th. Nauta Fonds", the UCB Award for Excellence in Medicinal Chemistry, established by UCB S.A. and the Prous Award in New Technologies in Drug Discovery, established by Prous Institute for Biomedical Research.

All 3 awards consist of a diploma, € 7.500 and an invitation for a lecture by the Award recipient at the upcoming EFMC-ISMC International Symposium on Medicinal Chemistry.


Laureates 2006:

Prof. Philip Portoghese, Department of Medicinal Chemistry, University of Minnesota, USA
Winner of the 2006 Nauta Award for Pharmacochemistry

Professor Portoghese receives this award for his many contributions to the field of GPCR science which have led to greater understanding of the way in which these receptors function. He is also recognised for his huge contribution to the scientific community as editor-in-chief of The Journal of Medicinal Chemistry.

Dr Bernd Riedl, Director at BayerHealthCare AG, Leverkusen, Germany
Winner of the 2006 UCB Award for Excellence in Medicinal Chemistry

Dr. Riedl receives this award for his outstanding scientific work leading to the discovery of the raf-kinase inhibitor Sorafenib (Bay-43-9006, Nexavar), the first example of the discovery of a new medicine which combines classical rationale drug discovery approach with the use of new technologies.

Prof. Dario Neri, Swiss Federal Institute of Technology (ETH) Zürich, Switzerland
Winner of the 2006 Prous Science Award for New Technologies in Drug Discovery

Professor Neri receives this award for his pioneering work establishing synthetic antibody libraries obtained employing phage display technology. Although this technology is still in its early stages, it holds significant potential for the discovery of new LMW binders to variety of protein targets.

The Awards are conferred on the occasion of the XIXth EFMC International Symposium on Medicinal Chemistry on the 29. of August at 5 p.m. during the opening ceremony


Job portal

12/01/2018
Synthetic Organic and Medicinal Chemists, Vernalis Research: Chemistry, Cambridge, United Kingdom
read more


20/04/2017
Medicinal / Synthetic Organic Chemists, Concept Life Sciences: Drug Discovery, Sandwich, Kent, United Kingdom
read more


Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRoche
 Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerck